ScreenerHero
DMPDermapharm Hldg SE
XETRA · DE · Healthcare · Drug Manufacturers - Specialty & Generic · ir.dermapharm.de
39.90EUR0.00%Mkt Cap: 2.15B $P/E: 14.89

Dermapharm Holding SE, together with its subsidiaries, manufactures and sells off-patent branded pharmaceutical products in Germany, Italy, France, Austria, Switzerland, Spain, Portugal, the Netherlands, Croatia, Poland,…

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
MERCK Kommanditgesellschaft auf Aktien
$65.24BUSDP/E 23.7
HLN
Haleon plc American Depositary Shares (Each representing two Ordinary Shares)
$43.41BUSDP/E 20.1
ZOE
Zoetis Inc.
$29.37BUSDP/E 12.4
UTHR
United Therapeutics Corporation
$22.70BUSDP/E 19.0
VTRS
Viatris, Inc.
$18.66BUSD
SOBI
Swedish Orphan Biovitrum AB
$15.39BUSDP/E 118.0
NBIX
Neurocrine Biosciences, Inc.
$15.81BUSDP/E 22.8
IPN
Ipsen S.A.
$14.67BUSDP/E 26.5
ELAN
Elanco Animal Health Incorporat
$12.24BUSD
KRK
Krka, d. d.
$8.57BUSDP/E 18.8
HIMS
Hims & Hers Health, Inc.
$7.25BUSD
LQDA
Liquidia Corporation
$6.74BUSDP/E 53.8
LNTH
Lantheus Holdings Inc
$6.56BUSDP/E 24.0
AMRX
Amneal Pharmaceuticals, Inc.
$6.23BUSDP/E 37.3
INDV
Indivior PLC Ordinary Shares
$4.61BUSDP/E 14.0
HIK
Hikma Pharmaceuticals PLC
$4.32BUSDP/E 12.5
AMLX
Amylyx Pharmaceuticals Inc. Common Stock
$4.30BUSD
SFZN
Siegfried Holding AG
$3.91BUSDP/E 20.4
ROVI
Laboratorios Farmaceuticos Rovi, S.A.
$3.34BUSDP/E 16.6
SUPN
Supernus Pharmaceuticals, Inc.
$2.82BUSD
HeadlineSourceTime
Older
Dermapharm steigert Ebitda um 10 Prozent und bestätigt Prognose
Wallstreet Online
DERMAPHARM lieferte solide Halbjahreszahlen
FinanzNachrichten.de
Dermapharm-Aktie schwächelt dennoch: Wachstum dank Markenarzneien
finanzen.net
Dermapharm-Aktie schwächelt dennoch: Wachstum dank Markenarzneien
finanzen.net
Dermapharm Hold (Jefferies & Company Inc.) 11.08.2026 | Analyse
finanzen.net
Dermapharm: EBITDA steigt, Prognose für 2026 bestätigt
4investors.de
Dermapharm Holding: Profitables Wachstum im 1. Halbjahr – Prognose bestätigt
Wallstreet Online
EQS-AFR: Dermapharm Holding SE: Vorabbekanntmachung über die Veröffentlichung von Finanzberichten gemäß §§ 114, 115, 117 WpHG - boerse.de
boerse.de
Dermapharm Holding Delivers Profitable H1 Growth, Confirms 2026 Outlook
Wallstreet Online
EQS-News: Dermapharm Holding SE wächst im ersten Halbjahr 2026 profitabel und bestätigt Prognose - boerse.de
boerse.de
Dermapharm Holding SE: Vorabbekanntmachung über die Veröffentlichung von Finanzberichten gemäß §§ 114, 115, 117 WpHG
TradingView
Dermapharm Holding-Aktie unter 200-Tage-Linie
boerse.de
Dermapharm Holding-Aktie über 200-Tage-Linie
boerse.de
Dermapharm Holding-Aktie unter 200-Tage-Linie
boerse.de
Dermapharm Holding-Aktie über 200-Tage-Linie
boerse.de
Dermapharm Holding SE Aktie: Umsatz, Wachstum & Cashflow
Goldesel.de
Dermapharm Holding Aktie deutlicher Kursrutsch - 17.07.2026
Wallstreet Online
Bafin versetzt Dermapharm-Aktie in Absturz: Prüfung des Abschlusses 20
Goldesel.de
Finanzaufsicht Bafin untersucht Jahresabschluss von Dermapharm ()
aktiencheck.de
SDAX-Titel Dermapharm-Aktie: Dermapharm passt Dividende nach unten an
Finanzen.net
Ihre wichtigsten Termine: Dermapharm Aktie, Kingfisher & Easyjet stehen heute im Blickpunkt der Analysten!
FinanzNachrichten.de
wO Heimspiel: Nischenpharma mit 43-%-Marge: Das Dermapharm-Dilemma für Investoren
FinanzNachrichten.de
Earnings Update: Here's Why Analysts Just Lifted Their Dermapharm Holding SE (ETR:DMP) Price Target To €47.88

Shareholders of Dermapharm Holding SE ( ETR:DMP ) will be pleased this week, given that the stock price is up 12% to...

Simply Wall St.
Here's Why We Think Dermapharm Holding (ETR:DMP) Is Well Worth Watching

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

Simply Wall St.
Can Dermapharm Holding SE's (ETR:DMP) ROE Continue To Surpass The Industry Average?

While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...

Simply Wall St.
The Dermapharm Holding SE (ETR:DMP) Half-Year Results Are Out And Analysts Have Published New Forecasts

Investors in Dermapharm Holding SE ( ETR:DMP ) had a good week, as its shares rose 4.2% to close at €34.40 following...

Simply Wall St.
Shareholders in Dermapharm Holding (ETR:DMP) are in the red if they invested five years ago

For many, the main point of investing is to generate higher returns than the overall market. But in any portfolio...

Simply Wall St.
Will Improving Profitability Despite Lower Sales Change Dermapharm Holding’s (XTRA:DMP) Investment Narrative?

Dermapharm Holding SE recently released earnings for the second quarter and first half of 2025, reporting sales of €275.48 million for the quarter and €580.75 million for the half-year, both slightly lower than the prior year. Despite lower sales, quarterly net income increased, highlighting a focus on operational efficiency even as half-year profit fell compared to last year. We’ll explore how Dermapharm’s ability to improve quarterly profitability amid softer sales shapes the company’s...

Simply Wall St.